QA: Sonoma Pharmaceuticals Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001367083_2026_Sonoma_Pharmaceuticals_Inc.pdf

Logs

Graph

Absolute values for 0001367083, Sonoma Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 12,648,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 225,000
3 remainder_Assets 820,000
4 LiabilitiesCurrent 4,096,000
5 LiabilitiesNoncurrent 27,000
6 remainder_Liabilities 5,159,000
7 CostOfGoodsAndServicesSold 8,741,335
8 SellingGeneralAndAdministrativeExpense 7,290,498
9 ResearchAndDevelopmentExpense 1,818,242
10 remainder_Expenses 321,564
11 remainder_Revenues 14,508,424
12 remainder_NetIncome 429,542
13 remainder_ComprehensiveNetIncome -887,556
  yvar yval
0 Assets 13,693,000
1 Liabilities 9,282,000
2 Expenses 18,171,639
3 Revenues 14,508,424
4 StockholdersEquity 4,411,000
5 NetIncome -3,233,673
6 ComprehensiveNetIncome -3,677,451
7 BaseVar 28,486,080
8 EconomicCapitalRatiobeforeLimitedLiability 0.517
9 EconomicCapitalRatio 1.90

Edgar->Model Mapping

Feature Distribution

Change over Time